¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neutral fat"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fat metabolism
    Áö¹æ´ë»ç
  • fat necrosis
    Áö¹æ±«»ç
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • fat-free body mass
    Áö¹æÁ¦¿ÜüÁß
  • fat-soluble
    Áö¿ë¼º-
  • fat-storing cell
    Áö¹æÀúÀå¼¼Æ÷
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • fascia-fat flap
    ±Ù¸·Áö¹æÇÇÆÇ
  • hypodermic fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • infrapatellar fat pad
    ¹«¸­¾Æ·¡Áö¹æÃ¼
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • molecular fat
    ºÐÀÚÁö¹æ
  • mutton-fat keratic precipitate
    ±»±â¸§°¢¸·Ä§Âø¹°
  • masked fat
    ¼ûÀºÁö¹æ
  • nodular fat necrosis
    °áÀýÁö¹æ±«»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat
    Áö¹æ
  • fat-soluble
    Áö¿ë¼º-
  • fascia-fat flap
    ±Ù¸·Áö¹æÇÇÆÇ
  • fat blood level
    Áö¹æÇ÷Ãþ
  • fat induced hyperlipemia
    ÁöÁúÀ¯µµ°íÁö¹æÇ÷Áõ
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • hypodermic fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • masked fat
    °áÇÕÁö¹æ
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • molecular fat
    ºÐÀÚÁö¹æ
  • pararenal fat
    ÄáÆÏÁÖÀ§Áö¹æÃ¼
  • perirenal fat
    ÄáÆÏÁö¹æÇǸ·
  • subcutaneous fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neutral refractories
    Áß¼º³»È­¹°(~Ò±ûýÚª).
  • neutral salt
    Áß¼º¿°(ñéàõç¤).
  • neutral zone
    Áß¼º´ë(ñéàõÓá) »ö¸Í .
  • bone fat
    °ñÁö(Íéò·).
  • breast,traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ±«»ç (èâß¿àõò·Û¸ÎÕÞÝ)
  • brown fat
    ºê¶ó¿î Áö¹æ(ò·Û°)
  • brown fat
    °¥»öÁö¹æ(ü)(¡­ò·Û¸ô÷).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷(¡­ò·Û¸ðÚòÄ).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
  • depot fat
    ÀúÀåÁö¹æ(îÍíúò·Û¸).
  • elbow fat pad sign
    ÆÈ²ÞÄ¡ Áö¹æ ÆÐµå¡ÈÄ(~ó£ý¦).
  • embolism,fat
    Áö¹æ(ò·Û¸)
  • fat
    Áö¹æ(ò·Û¸).
  • fat atrophy
    Áö¹æ À§Ãà
  • fat blood level
    Áö¹æÇ÷ Ãþ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • true fat
    Áø¼ºÁö¹æ(òØàõò·Û¸)
  • white fat
    ÈØ Áö¹æ (ò·Û¸)
  • wool fat
    ¾çÅÐÁö¹æ(ò·Û¸)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • phase evolution of fat suppression
    À§»ó¼±È¸ Áö¹æ¾ïÁ¦
  • subcutaneous fat
    ÇÇÇÏÁö¹æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LNAA large neutral amino acid
NAA N-acetyl aspartate; naphthaleneacetic acid; neutral amino acid; neutron activation analysis; neutrop...
ND Doctor of Naturopathy; nasal deformity; natural death; Naval Dispensary; neonatal death; neoplastic ...
NEP negative expiratory pressure; nephrology; neutral endopeptidase; no evidence of pathology
neut neuter, neutral; neutrophil
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NPH Neutral Protamine Hagedorn
NR Neutral Red
NAA Neutral amino acid
ND Neutral density
NDF Neutral detergent fiber
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fat suppression
    Áö¹æ ¾ïÁ¦
  • frequency selective fat suppression technique
    ÁÖÆÄ ¼ö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý, Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý
  • hypodermic fat
    ÇÇÇÏ Áö¹æ
    ÇÇÇÏ Á¶Á÷¿¡ Á¸ÀçÇÏ´Â Áö¹æÃþ.
  • multilocular fat cell
    ¹µÄ­ Áö¹æ ¼¼Æ÷
  • pararenal fat pad
    ÄáÆÏ ÁÖÀ§ Áö¹æÃ¼
  • perirenal fat
    ½Å ÁÖÀ§ Áö¹æ
  • polyunsaturated fat
    ´ÙºÒÆ÷È­ Áö¹æ
    carbon chain¿¡¼­ ÇÑ °³ ÀÌ»óÀÇ ÀÌÁß °áÇÕÀ» °®°í ÀÖ´Â Áö¹æ»êÀ» ÇÔÀ¯ÇÏ´Â Áö¹æ.
  • traumatic fat necrosis
    ¿Ü»ó¼º Áö¹æ ±«»ç
  • traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ ±«»ç
  • white fat tissue
    ¹é»ö Áö¹æÁ¶Á÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
neutral point The point at which a solution is neither acid nor alkaline (pH 7 at 22°C for aqueous solutions).
(05 Mar 2000)
neutral protease <enzyme> Protease that is optimally active at neutral pH:
See: proteases.
(18 Nov 1997)
neutral reaction PH of 7.00; H+ and OH- ion concentrations equal at 10-7 m at 22°C.
Compare: dissociation constant of water.
(05 Mar 2000)
neutral red <chemical> 3-amino-7-dimethylamino-2-methylphenazine hydrochloride. A vital dye used as an indicator and biological stain. Various adverse effects have been observed in biological systems.
Pharmacological action: dyes, indicators and reagents.
Chemical name: 2,8-Phenazinediamine, N8,N8,3-trimethyl-, monohydrochloride
(12 Dec 1998)
neutral spirits Spirits distilled from suitable raw materials, are 95% ethanol (v/v) that is, at least 190 proof when distilled. Used for blending with straight whiskey and for making gin, cordials, liqueurs, and vodka.
See: alcohol.
Proof spirit, dilute alcohol, specific gravity 0.920, containing 49.5% by weight (57.27% by volume) of C2H5OH at 15.56°C. Originally in Great Britain it was the weakest alcohol that would permit ignition of gunpowder moistened with it. British proof spirit has a specific gravity of 0.9198 and contains 49.2% C2H5OH by weight, or 57.1% by volume at the temperature of 10.56°C.
(05 Mar 2000)
neutral stain <technique> A compound of an acid stain and a basic stain, such as the eosinate of methylene blue, in which the anion and cation each contains a chromophore group.
Synonym: salt dye.
(05 Mar 2000)
neutral stimulus When paired with the unconditioned stimulus in simultaneous presentation to an organism, capable of eliciting a given response.
(05 Mar 2000)
neutral zone In dentistry, the potential space between the lips and cheeks on one side and the tongue on the other; natural or artificial teeth in this zone are subject to equal and opposite forces from the surrounding musculature.
(05 Mar 2000)
day neutral plant <botany> Plants that flower regardless of day length.
(09 Oct 1997)
lens neutral proteinase <enzyme> Degrades alpha 2-crystallin; requires ca and mg; cleaves phe-ser bond in bradykinin; similar enzyme found in human lung
Registry number: EC 3.4.24.5
Synonym: neutral proteinase 24.5
(26 Jun 1999)
abdominal wall fat pad biopsy <investigation, procedure, surgery> The removal of a small specimen of the abdominal wall fat pad for microscopic examination. Often used in the diagnosis of amyloidosis. Performed with a local anaesthetic.
(25 Jun 1999)
Bichat's fat-pad An encapsuled mass of fat in the cheek on the outer side of the buccinator muscle, especially marked in the infant; supposed to strengthen and support the cheek during the act of sucking.
Synonym: corpus adiposum buccae, Bichat's fat-pad, Bichat's protuberance, fat body of cheek, sucking cushion, sucking pad, suctorial pad.
(05 Mar 2000)
brown fat A thermogenic type of adipose tissue containing a dark pigment, and arising during embryonic life in certain specific areas in many mammals, including man. It is prominent in the newborn of all species in which it occurs and remains a distinct and conspicuous tissue in the adults of certain species, especially those that hibernate. It is also called brown adipose tissue.
(12 Dec 1998)
brown fat cell <pathology> Brown fat is specialised for heat production and the adipocytes have many mitochondria in which an inner membrane protein can act as an uncoupler of oxidative phosphorylation allowing rapid thermogenesis.
(18 Nov 1997)
buccal fat-pad An encapsuled mass of fat in the cheek on the outer side of the buccinator muscle, especially marked in the infant; supposed to strengthen and support the cheek during the act of sucking.
Synonym: corpus adiposum buccae, Bichat's fat-pad, Bichat's protuberance, fat body of cheek, sucking cushion, sucking pad, suctorial pad.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neutral mutation
    Á߸³µ¹¿¬º¯ÀÌ
  • neutral spirits
    Áß¼º ÁÖÁ¤(95µµ ÀÌ»ó¼ø¼ö ¾ËÄÚ¿Ã,º¸Åë ´Ù¸¥ ¼ú°ú ¼¯¾î¸¶½É)
  • neutral tint
    Áß°£»ö;¿¬ÇÑȸ»ö
  • neutral zone
    Áß°£Áö´ë
  • puppy fat
    (À¯¾Æ±â,»çÃá±âÀÇ ÀϽÃÀû) ºñ¸¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á